Oxford Lane Capital: Q3 Results Confirms My Optimism On Deal Activity (Archive) Record deal growth and rising CLO reinvestment periods, but dilution tempers per-share upside.
Oxford Lane Capital Q2 FY25 Preview: Expecting Vibrant Deal Activity (Archive) Poised to gain from vibrant CLO deal growth amid reasonable premium-to-NAV valuations.
Oxford Lane Capital: Why I Think This Is A Yield Trap (Archive) Highlighting unsustainable payouts from negative cash flows and premium-valued, underwater investments.
Oxford Lane Capital: Fundamental Issues Aside, Rate Cuts Are A Tailwind (Archive) Rate cuts offer OXLC a fragile tailwind amid chronic cash flow and NAV erosion.
Oxford Lane Capital Is In A Slump With No Signs Of Recovery (Archive) Oxford Lane’s high yield masks weakening cash flows, dilution, and shrinking NAV-driven returns.